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Abstract
Purpose Use of polypropylene mesh (PPM) in hernia
repair is associated with tissue reactivity. We examined, in
a rat model, a novel non-biodegradable hydrogel coated
PPM which may allow for decreased inflammation and a
decreased foreign body reaction.
Methods Through a dorsal midline incision, a
2 cm 9 2 cm section of PPM (either coated or uncoated)
was placed on the fascial surface 1.5 cm from the incision
on the dorsal wall of Sprague–Dawley rats. At 2 and
12 weeks after placement, the PPM and surrounding tissue
were harvested. A board-certified dermatopathologist
examined H&E stained slides for fibrosis and foreign body
reaction. In addition, tissues were stained for apoptotic
cells, oxidative damage, macrophages, fibroblasts, neo-
vascularization and metalloproteases.
Results At 2 and 12 weeks, there was a greater than 95 %
decrease in foreign body giant cells in coated PPM samples
compared to uncoated; fibrosis was decreased by 50 %. At
2 and 12 weeks, oxidative damage, fibroblast accumula-
tion, apoptosis and macrophages were significantly
decreased in coated PPM samples compared to uncoated
PPM.
Conclusion These results demonstrate that a non-
biodegradable hydrogel coating of PPM led to significant
reduction in foreign body reaction, oxidative stress and
apoptosis compared to uncoated PPM in vivo, and suggest
that this coating could be clinically useful in hernia repair.
Keywords Hydrogel  Hernia repair  Polypropylene
mesh  Foreign body reaction
Introduction
Since the introduction of Marlex mesh by Usher in 1958
[1], polypropylene mesh (PPM) has become a mainstay in
hernia repair [2, 3]. While it has revolutionized the field,
PPM has also been associated with significant morbidities
including, pain, erosion, migration and adhesion formation
[4–6]. Since both surgical techniques and indications for
mesh placement vary, development of an ‘‘ideal’’ mesh,
suitable for all purposes, may not be possible. However, it
is generally agreed that limiting the foreign body response
(FBR) is an important step in developing a biocompatible
mesh.
The FBR is part of the cascade of events that occurs
when a foreign material is implanted. Occurring to differ-
ent degrees in different tissues, the response to implanted
materials includes blood–material interactions, acute
inflammation, chronic inflammation, FBR, and fibrous
encapsulation [7]. Briefly, when a biomaterial is implanted,
it is immediately coated with surface proteins. At the same
time, acute inflammation occurs, as neutrophils are
attracted to the implanted biomaterial. The neutrophils
attempt to engulf the biomaterial, but its large size prevents
this, and leads to a process known as ‘‘frustrated phago-
cytosis’’ [8] and release of inflammatory mediators at the
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site. This is followed by entry of other inflammatory cells,
including monocytes, macrophages and lymphocytes,
along with neovascularization and proliferation of con-
nective tissue, resulting in a chronic inflammatory process.
Chronic inflammation is followed by the FBR, which is the
accumulation of both foreign body giant cells (FBGC),
which are fused macrophages, and granulation tissue, the
aggregation of new blood vessels and connective tissue.
Finally, there is a fibrotic encapsulation of the biomaterial
which follows the FBR.
In addition to limiting the FBR, an ideal mesh would be
one that was ‘‘technically easy to place, did not incite a
chronic inflammatory response, did not degrade over time,
resulted in minimal shrinkage, was resistant to infection,
resulted in excellent healthy tissue integration, and no
adhesion formation, small-bowel obstructions, or fistulas,
and resulted in a durable repair’’ [9]. In this paper, the
properties of a non-biodegradable hydrogel coated PPM are
demonstrated in comparison to a bare uncoated PPM. A
hydrogel coating for PPM has been developed which has a
novel Polyurethane backbone, similar to polyurethanes that
have been used for long-term implants in patients (see
‘‘Methods’’). In this study, we tested the hydrogel coated
PPM and compared it to an uncoated PPM to determine the
potential of the hydrogel coated PPM to address the limi-
tations of the naked PPM that are commercially available,




The non-biodegradable hydrogel coating is a synthetic,
long chain polyol on a Polyurethane backbone, and was
supplied by promethean surgical devices (PSD; East
Hartford, CT). A schematic of the polymer, depicting its
novel trifunctionality, is shown in Fig. 1. Hydrophilic
zones, depicted by blue circles, draw water into the poly-
mer, while hydrophobic zones (green circles) expel water
from the polymer. The red circles depict linking groups
that provide for crosslinking of the hydrogel on the PPM.
The presence of both hydrophilic and hydrophobic sites on
the polymer surface allows for the constant exchange of
water molecules on the hydrogel surface and its immediate
environment. The hydrogel coating used in this study is
FDA approved and has passed the following preclearance
tests: 10993-3, genotoxicity; ‘‘Big Blue’’ transgenic mouse
model, carcinogenicity; 10993-4, hemolysis of blood;
10993-5, cytotoxicity; 10993-6, implantation compatibil-
ity; 10993-10, sensitivity; 10993-11, systemic toxicity.
PPM was coated in a proprietary process with hydrogel in a
commercial facility (PSD). Both light micrographs (A, B)
and SEM images (C, D) are shown in Fig. 2. The
monofilaments of the mesh, the interstices and the knots
are clearly visible in the uncoated mesh, whereas they are
covered ([98 %) in the coated mesh.
PPM implantation
Sprague–Dawley rats were used for these studies, which
were carried out at the University of Missouri School of
Medicine. Either coated or uncoated PPM was implanted
and animals were euthanized at either 2 weeks
(n = 10/group; acute) or 12 weeks (n = 8/group; long
term). To implant the PPM, rats were anesthetized and a
2 cm longitudinal incision was made off the left dorsal
midline. This approach has been determined to prevent
animal self-mutilation of wounds when compared to a
ventral incision to study implant tissue reactions. The
subcutaneous tissues were bluntly dissected off of the
central and right-sided abdominal musculature to create a
subcutaneous pocket. A 2 cm 9 2 cm piece of sterile PPM
was placed on the fascial surface at least 1.5 cm from the
incision; four 4-0 Prolene sutures were used to fix and mark
the PPM location. At 2 and 12 weeks, a 3 cm full thickness
section of the dorsal wall was harvested for analysis. All
animal protocols were approved by the IACUC and fol-
lowed institutional guidelines.
Histology
Tissue samples were embedded in paraffin and sections
were made. The histologic analysis was carried out at Weill
Cornell Medical College by independent board-certified
dermatopathologists, blinded to the treatment. H&E stained
slides were analyzed for fibrosis, foreign body giant cells,
eosinophils, polymorphonuclear leukocytes (PMN), histi-
ocytes and lymphocytes.
Immunohistochemistry
Slides were stained for oxidative stress [staining for
8-hydroxydeoxyguanosine (8-OHdG)], apoptotic cells
(TUNEL assay), macrophages and fibroblasts as previously
described [10, 11]. Cells were counted in 10 high power
fields (HPF). Neovascularization was identified by staining
for CD31 (Santa Cruz, Monoclonal antibody). Staining for
matrix metalloprotease-2 was also performed.
Attenuated total reflectance Fourier transform
infrared spectroscopy (ATR-FTIR)
ATR-FTIR was used to measure surface mesh oxidation
[12]. ATR-FTIR measures IR intensity versus wavelength
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of light by detecting vibration characteristics of chemical
functional groups, and detects if chemical changes to the
surface of the material are present. Samples of PPM were
removed from the rats and placed in sodium hypochlorite
for 2 h (uncoated PPM) or 3 h (coated PPM; the coating
necessitated a longer incubation time, which did not affect
Fig. 1 Schematic of hydrogel
polymer. The hydrogel
comprises hydrophilic zones
(blue circles) that draw water
into the polymer and
hydrophobic zones (green
circles) that expel water from
the polymer. Linking groups
(red circles) provide for
crosslinking of the hydrogel on
to the mesh
Fig. 2 Images of uncoated and
coated PPM. Light microscope
images (950 magnification) of
uncoated (a) or coated (b) PPM.
SEM images (950
magnification) of uncoated
(c) or coated (d) PPM
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the results). After cleaning and drying, PPM was placed on
the ATR crystal and subjected to ATR-FTIR. The presence
of a carbonyl peak was analyzed via a peak area integration
program in the OMNIC software package.
Statistical analysis
All data are reported as mean ± SEM. We performed the
Wilcoxon rank sum test (non-parametric test) to compare




At 2 weeks following implantation, the tissue was evalu-
ated for the presence of foreign body giant cells (FBGC),
other inflammatory cells and fibrosis. There were
1.78 ± 0.59 FBGC/HPF in areas adjacent to uncoated
PPM, whereas there were only 0.06 ± 0.02 FBGC in areas
adjacent to coated PPM (p\ 0.01) (Table 1; Fig. 3a, b).
There were significantly less histiocytes and eosinophils as
well in the coated PPM samples (Table 1). The lack of
reactivity was confirmed by the finding that there was also
a significant decrease in fibrosis in the coated PPM samples
as compared to the uncoated (0.09 ± 0.03 vs.
0.18 ± 0.06 mm, respectively, p\ 0.05; Fig. 3c, d). At
12 weeks, the results were very similar (Table 1). FBGC
were still decreased by 90 % in coated PPM, compared to
uncoated. Eosinophils and histiocytes were significantly
decreased and there was 50 % less fibrosis around the
coated PPM. There were significantly more macrophages
in the uncoated samples than in the coated samples
(Table 1; Fig. 4a, b) at 12 weeks.
Fibroblast expression
We examined tissue for the presence of fibroblasts by
staining for the presence of Fibroblast Specific Protein-1
[13]. At 2 weeks there were 24.4 ± 2.2 FSP? cells/HPF in
areas adjacent to uncoated PPM; in contrast there were
only 13.3 ± 5.4 FSP? cells/HPF in areas adjacent to
coated PPM (Table 1; Fig. 4c, d). Similar results were
found at 12 weeks (Table 1).
Apoptosis
The TUNEL assay was used to determine if there were
apoptotic cells in the tissue. At 2 weeks, in samples from
the animals implanted with uncoated PPM there were
13.1 ± 1.1 apoptotic cells/HPF (Table 2; Fig. 5a–c) This
was decreased by almost 90 % in samples from animals
implanted with coated PPM (1.5 ± 0.2 cells/HPF;
p\ 0.001). At 12 weeks, TUNEL positive cells in the
uncoated PPM samples were 11.0 ± 1.1 cells per HPF,
whereas in the coated mesh PPM there were 2.0 ± 0.4
(p\ 0.001; Table 2).
Oxidative stress
Cells were examined for the presence of 8-OH deox-
yguanosine (8-OHdG), which detects the presence of
oxidative stress on an intracellular level by attaching to
DNA damaged by cellular oxidation. In the samples taken
from animals implanted with uncoated PPM at 2 weeks
there were 20.3 ± 1.4 8-OHdG positive cells/HPF
(Table 2). In coated PPM samples, 6.7 ± 1.2 cells/HPF
(p\ 0.001) were found, a decrease of over 70 %. At
12 weeks there were 8-OHdG positive cells 31.9 ± 2.3 per
HPF in uncoated PPM samples, compared to 9.3 ± 1.7 in
coated (p\ 0.001; Fig. 6a, b). ATR-FTIR was used as an
Table 1 Histological analysis
of 2 and 12-week tissue
2 weeks 2 weeks 12 weeks 12 weeks
Uncoated Coated Uncoated Coated
Fibrosis (mm) 0.18 ± .06 0.09 ± 0.03* 0.16 ± 0.03 0.05 ± 0.02**
Foreign Body Giant Cells 1.78 ± 0.59 0.06 ± 0.02** 2.11 ± 0.12 0.20 ± 0.22
Eosinophils 2.89 ± 0.96 0.06 ± 0.06 1.89 ± 0.28 0.20 ± 0.20}
PMNs 0.78 ± 0.26 0.39 ± 0.14 0.78 ± 0.16 0.80 ± 0.22
Histiocytes 2.38 ± 0.79 1.11 ± 0.39} 2.56 ± 0.19 1.60 ± 0.27**
Lymphocytes 1.75 ± 0.58 2.00 ± 0.71 1.56 ± 0.19 1.8 ± 0.22
Macrophages 73.3 ± 11.4 21.8 ± 2.1** 42.1 ± 12.3 22.8 ± 5.5
Fibroblasts (FSP? cells) 24.4 ± 2.2 13.3 ± 5.4} 23.5 ± 2.8 14.8 ± 2.7*
Fibrosis (mm) and Foreign Body Giant Cell, Eosinophil, PMN, Histiocyte and Lymphocyte counts were
determined by the dermatopathologist. Macrophage and Fibroblast counts were obtained from
immunohistochemistry
Compared to Uncoated: * p\ 0.05; ** p\0 .01; } p\ 0.001;  p\ 0.0001
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indirect measure of the surface oxidation of the mesh. A
spectrum is shown in Fig. 7a and a graphical representation
of the results is shown in Fig. 7b. The uncoated PPM
showed significantly higher carbonyl peaks than the coated
PPM (0.24 ± 0.22 vs. 0.07 ± 0.07; p\ 0.05).
Neovascularization
An antibody to CD31 was used to determine if there were
new blood vessels in the samples. We then calculated the
CD31-positive area as a percent of the total area. We found
that at 2 weeks, the percent CD-31 positive area in the
uncoated samples was 9.01 ± 1.47 % (Fig. 8a, c; Table 2)
compared to 14.68 ± 1.38; p\ 0.01 in the coated samples
(Fig. 8b, d; Table 2). Thus in contrast to measures of tissue
damage, which were all less in the coated samples, there
was more neovascularization in the coated samples. This is
a positive indicator of healthy tissue growth. This differ-
ence persisted at 12 weeks.
MMP-2: Tissues were stained for matrix metallo-
protease-2. MMP-2 staining in the uncoated PPM was
found directly around the implant. In the coated mesh
samples there was almost no MMP-2 staining (Fig. 9a,
b). This finding supports a lower tissue reaction to
coated mesh.
Discussion
Polypropylene mesh has become a mainstay of hernia
repair [2, 3]. The strength and durability of the material has
improved outcomes, but the reaction to the mesh by host
tissues is unpredictable and often undesirable. The desire to
minimize inflammatory reactions, while maintaining the
integrity of the mesh, has led to the development of
materials and changes in geometry (pore size and material
weight) in an attempt to preserve the good qualities and
mitigate the bad. In this study, we demonstrated that
coating PPM with a novel non-biodegradable hydrogel
resulted in a significant decrease in the immediate and
chronic foreign body responses. The number of foreign
body giant cells found at 2 weeks was decreased by 95 %
and this persisted over 12 weeks. Fibrotic encapsulation
was greatly decreased, as were apoptotic cells, oxidative
stress and MMP-2 expression. Thus, coating PPM with
hydrogel can significantly mitigate the negative reactions
associated with uncoated PPM in use today for surgical
repair of hernias.
Curtailing the FBR should mitigate many of the negative
reactions of the host to PPM implantation. The first stage of
the acute FBR is the adsorption of proteins onto the surface
of the implant. Once proteins adsorb, they can be replaced
Uncoated PPM Coated PPM
A B
C D
Fig. 3 H&E stain of 2-week samples of implanted PPM. H&E
stained samples of both uncoated (a) and coated (b) PPM are shown.
In c (uncoated) and d (coated) the width of the fibrotic area is shown
by the blue arrows. Note the lack of Foreign Body Giant Cells in the
coated PPM compared to uncoated. Quantification of fibrosis and
Foreign body giant cells is given in Table 1
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by proteins of higher affinity in a process known as the
Vroman effect [14]. This results in attachment of proteins
to the foreign implant, which leads to continued chronic
FBR and subsequent fibrotic encapsulation and contraction
of the implant. One of the unique features of the hydrogel
coating used herein is shown in Fig. 1. The presence of
both hydrophilic and hydrophobic sites on the hydrogel
allows for a constant exchange of water molecules at the
surface. Brownian motion ensures that water is constantly
entering and leaving the polymer surface, preventing pro-
tein attachment which mitigates the Vroman effect. This
was borne out in this study where it was shown that the
number of foreign body giant cells found at 2 weeks was
decreased by 95 % and this persisted over 12 weeks.
Fibrotic encapsulation of the coated PPM was also greatly
reduced compared to uncoated PPM. Furthermore, when
we examined the mesh/tissue interface for expression of
Fibroblast specific protein-1, a marker for fibroblasts, we
found a significant decrease in fibroblasts at both 2 and
12 weeks. Despite effects on the FBR, we do not anticipate
effects of the coated mesh on wound healing in patients.
Short-term mechanical strength is maintained due to the
elastic and tissue-like bending modulus the mesh provides.
Normal wound healing response provides the maximum
healing response and viable scar tissue development to
further support the surgical wound over time. Healthier
scar tissue (well vascularized tissue) allows for tissue
regeneration and immunologic resistance to infection. In
the long term, the surgical wound is supported with the
Mesh substrate, with intact vascular tissue providing
A B
C D
Uncoated PPM Coated PPM
Fig. 4 Macrophages and fibroblasts in coated and uncoated PPM
samples. Macrophages were visualized with antibody to CD-68 in
12-week PPM samples. a Uncoated PPM. b Coated PPM. Fibroblasts
were visualized with antibody to FSP-1 in 2-week PPM samples.
c Uncoated PPM. d Coated PPM
Table 2 Apoptosis, oxidative
stress and neovascularization in
2 and 12-week tissue
2 weeks 2 weeks 12 weeks 12 weeks
Uncoated Coated Uncoated Coated
TUNEL? cells 13.1 ± 1.05 1.5 ± 0.2} 11.0 ± 1.1 2.0 ± 0.4}
8-OHdG? cells 20.3 ± 1.4 6.7 ± 1.2} 31.9 ± 2.3 9.3 ± 1.7}
Neovascularization % 9.01 ± 1.47 14.68 ± 1.38** 5.1 ± .4 9.6 ± 0.5}
Compared to Uncoated: ** p\ 0.01; } p\ 0.001
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continued immunologic support for a pain-free/infection
free/complication-free outcome.
The second phase of the FBR is the acute inflammatory
response which results in neutrophil attraction to the
implant site [7, 8]. As shown, there was a 50 % reduction
in neutrophils at the 2-week time point. Following this is
the chronic inflammatory phase. At the early time point,
macrophages were decreased by over 50 % and eosinophils
by over 95 %. These results demonstrate a significant
decrease in the inflammatory response to the coated PPM
compared to the uncoated PPM. In assessing the response
of host tissues to various implanted mesh materials,
investigators have noted the importance of both fibroblasts
and macrophages to the healing response [15]. However,
the beneficial effects of these cells and their cytokines in
promoting healthy tissue ingrowth need to outweigh the
negative effects of an enhanced inflammatory response by
cytokines produced by both macrophages and fibroblasts,
which can lead to erosion and pain.
Neovascularity is critically important for healthy tissue
integration of PPM into the host [16, 17]. PPM implanta-
tion can lead to local tissue hypoxia, which can be miti-
gated by increased blood flow. Delivery of white blood
cells into the tissue/mesh interface area to prevent infection
and removal of debris related to the FBR produced by PPM
is also accomplished by local vascularity. In the current
study, we demonstrated a significant increase in neovas-
cularization in response to the coated PPM as compared to
the uncoated. These results are compatible with results






Fig. 5 Apoptotic cells
visualized with the TUNEL
stain Apoptotic cells in 2-week
PPM samples were visualized
with the TUNEL stain. a 2-
week, uncoated PPM. b Area
circled in a is enlarged in b;
individual nuclei are shown
with arrows. c Coated PPM,
showing almost no staining for
apoptotic cells
A B
Uncoated PPM Coated PPM
Fig. 6 Oxidative damage
visualized with 8-OHdG
staining. Cells positive for
oxidative damage in 12-week
PPM samples were visualized
with a stain for 8-OHdG.
a Uncoated PPM. b Coated
PPM
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replacement; it was shown that in that study that lack of
neovascularization was associated with increased fibrosis
[18].
It is thought that oxidation of mesh occurs in situ. In a
2007 study [19], mesh was taken from patients undergoing
revision of their hernia repair. Indirect evidence of mesh
oxidation was presented including scanning electron
microscopy showing cracks, roughness and peeling of the
mesh. In the present study, two different indicators of
oxidative stress were examined. We demonstrated a

























Fig. 7 Oxidative damage assessed with ATR-FTIR. Samples of PPM
were removed from the rats and placed in sodium hypochlorite for 2 h
(uncoated mesh) or 3 h (coated mesh). After cleaning and drying, the
meshes were placed on the ATR crystal and subjected to ATR-FTIR.
A Nicolet 6700 FT-IR spectrometer (Thermo Scientific, Waltham,
MA, USA) was utilized to collect spectra with 32 scans and a
resolution of 4 cm-1 at ambient temperature. Three scans were
performed per specimen. For the specimens, the presence of a
carbonyl peak was analyzed via a peak area integration program in the
OMNIC software package. The area of integration for the carbonyl
peak, which peaks at *1740 cm-1, was from 1700 to 1775 cm-1.
A A representative spectrum from ATR-FTIR experiments. Red line,
uncoated PPM. Purple line, coated PPM. b Graphical representation





Uncoated PPM Coated PPM
Fig. 8 Neovascularization assessed in 2-week PPM samples. Neovascularization was assessed by staining with an antibody to CD-31, using
either peroxidase (a, b) or fluorescence (c, d). Uncoated PPM is shown in a and c, and coated PPM is shown in b and d
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significant decrease in 8-OHdG, a measure of DNA oxi-
dation, in the coated PPM samples at both 2 and 12 weeks.
We also used ATR-FTIR analysis [12], which detects the
vibration characteristics of chemical functional groups in a
mesh sample. Chemical bonds will stretch, contract and
bend when infrared light interacts with the mesh sample.
Utilizing ATR-FTIR, the specimens were analyzed to
determine if the presence of functional groups such as C=O
were present on the surface. In this study, a significant
decrease in these oxidative species was documented in the
coated PPM compared to uncoated PPM. Thus, this study
provides direct evidence of both oxidation of PPM in vivo,
and its mitigation by the hydrogel coating.
It has also been shown that reactive oxygen and nitrogen
(RON) species can activate MMP-2 in the heart [20].
Biosynthesis of peroxynitrite, an RON, led to acute
mechanical dysfunction of myocardium followed by an
increase in MMP-2 activity; this was mitigated by inhibi-
tors of MMP-2. Infusion of RONS into the heart also
caused dysfunction, which was mitigated by MMP-2
inhibitors. We showed a qualitative distinction between
coated PPM and uncoated PPM in this study, with
decreased expression of MMP-2 in the coated samples.
Thus, this indirectly confirms a decreased oxidative stress
response with coated PPM.
Conclusion
In summary, the results of the current study provide evi-
dence that using this non-biodegradable hydrogel coating
provides a PPM which when placed in rats for 2 and
12 weeks results in almost no fibrosis or foreign body
response, limited oxidative stress and metalloprotease
activity, and no evidence of infection. Clinical outcomes in
hernia patients using the hydrogel coated mesh will need to
be performed to confirm these important findings. Such
studies could include monitoring surgical complications,
deep wound infection, seroma formation, adhesions and the
incidence of chronic pain, beginning at 3 months and
continuing to 12 months. Long-term outcomes could
include post-procedure mesh infections beyond 12 months
to 5 years, and continued chronic pain syndrome (i.e. hard
abdomen).
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Uncoated PPM Coated PPM
Fig. 9 Matrix metalloprotease-
2 staining in 2-week PPM
samples. Staining for MMP-2 is
shown for representative
sections of either. a Uncoated
PPM or b coated PPM
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